HA-1 Mismatch Has Significant Effect in Chronic Allograft Nephropathy in Clinical Renal Transplantation

Transplantation Proceedings

Volumn 39, Issue 5, 2007, Pages 1439-1445

  Krishnan, N S ^a   Higgins, R M ^a   Lam, F T ^a   Kashi, H ^a   Jobson, S ^c   Ramaiyan, K ^a   Rahman, M ^b   Morris, A ^b  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Regional Blood Transfusion Service   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HA 1 ANTIGEN; HLA A2 ANTIGEN; IMMUNOGLOBULIN G; MINOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL STIMULATION; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HLA MATCHING; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LEUKOCYTE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; STAINING;

ADULT; AGED; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA-A2 ANTIGEN; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; OLIGOPEPTIDES; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TRANSPLANTATION CHIMERA;

EID: 34250220594     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.02.066     Document Type: Article

References (22)

1. Goulmy E., Schipper R., Pool J., et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334 (1996) 281
2. Chao N.J. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease. Biol Blood Marrow Transplant 10 (2004) 215
3. Fabre J., and Morris P.J. Studies on the specific suppression of renal allograft rejection in presensitized rats. Transplantation 19 (1975) 121
4. Peugh W.N., Superina R.A., Wood K.J., et al. The role of H-2 and non H-2 antigens and genes in the rejectijon of murine cardiac allografts. Immunogenetics 23 (1986) 30
5. Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 157 (1997) 125
6. Claverie J.M., Kourilsky P., Langlade-Demoyen P., et al. T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein. Eur J Immunol 18 (1988) 1547
7. den Haan J.M., Meadows L.M., Wang W., et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279 (1998) 1054
8. Shlomchik W.D., Couzens M.S., Tang C.B., et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285 (1999) 412
9. Scott D.M., Ehrmann I.E., Ellis P.S., et al. Why do some females reject males?. The molecular basis for male-specific graft rejection. J Mol Med 75 (1997) 103
10. Wang W., Meadows L.R., den Haan J.M., et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269 (1995) 1588
11. Rufer N., Wolpert E., Helg C., et al. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. Transplantation 66 (1998) 910
12. Mutis T., Gillespie G., Schrama E., et al. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 5 (1999) 839
13. de Bueger M., Bakker A., Van Rood J.J., et al. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 149 (1992) 1788
14. Klein C.A., Wilke M., Pool J., et al. The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. J Exp Med 196 (2002) 359
15. Dickinson A.M., Wang X.N., Sviland L., et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 8 (2002) 410
16. Teshima T., Ordemann R., Reddy P., et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 8 (2002) 575
17. Cai J., Lee J., Jankowska-Gan E., et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 199 (2004) 1017
18. Yang J., Jaramillo A., Liu W., et al. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells. Transplantation 76 (2003) 84
19. Baker R.J., Hernandez-Fuentes M.P., Brookes P.A., et al. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 167 (2001) 7199
20. Shirwan H. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?. Transplantation 68 (1999) 715
21. La Rosa F.G., and Talmage D.W. The failure of a major histocompatibility antigen to stimulate a thyroid allograft reaction after culture in oxygen. J Exp Med 157 (1983) 898
22. Wilke M., Pool J., den Haan J.M., et al. Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens 52 (1998) 312